aztreonam has been researched along with Recrudescence in 10 studies
Aztreonam: A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
aztreonam : A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Eighty-two evaluable patients suffering from UTI were randomly treated with parenteral Aztreonam (1 g OD in cystitis and 1 g BID in pyelonephritis) or oral Norfloxacin (400 mg BID)." | 9.06 | [Aztreonam vs norfloxacin: a comparative study of the treatment of urinary tract infections in ambulatory and hospitalized patients]. ( De Rose, AF; Germinale, F; Puppo, P, 1989) |
| "Carumonam and gentamicin were compared in a prospective, randomized study of 52 patients with complicated urinary tract infections." | 9.06 | Carumonam (Ro 17-2301; AMA-1080) compared with gentamicin for treatment of complicated urinary tract infections. ( Bakker, LJ; Hoepelman, AI; Verhoef, J, 1988) |
| "However, bacteriological recurrence, related to the persistent nature of the underlying disease, occurred in 6 of the 10 patients during the 1-month follow-up period." | 6.65 | Clinical experience with aztreonam in urinary and respiratory tract infections. ( Donohoe, JF; Hollingsworth, JA; Hone, R; Keelan, PJ, 1984) |
| "Eighty-two evaluable patients suffering from UTI were randomly treated with parenteral Aztreonam (1 g OD in cystitis and 1 g BID in pyelonephritis) or oral Norfloxacin (400 mg BID)." | 5.06 | [Aztreonam vs norfloxacin: a comparative study of the treatment of urinary tract infections in ambulatory and hospitalized patients]. ( De Rose, AF; Germinale, F; Puppo, P, 1989) |
| "Carumonam and gentamicin were compared in a prospective, randomized study of 52 patients with complicated urinary tract infections." | 5.06 | Carumonam (Ro 17-2301; AMA-1080) compared with gentamicin for treatment of complicated urinary tract infections. ( Bakker, LJ; Hoepelman, AI; Verhoef, J, 1988) |
| " Dosage of aztreonam was 2 to 8 g per day administered intravenously or intramuscularly for five to 52 days." | 2.66 | Aztreonam in the treatment of serious orthopedic infections. ( Beskin, J; Beville, R; Haddad, RJ; Holmes, B; Mogabgab, WJ; Pollock, B; Pribyl, C; Salzer, R, 1985) |
| "However, bacteriological recurrence, related to the persistent nature of the underlying disease, occurred in 6 of the 10 patients during the 1-month follow-up period." | 2.65 | Clinical experience with aztreonam in urinary and respiratory tract infections. ( Donohoe, JF; Hollingsworth, JA; Hone, R; Keelan, PJ, 1984) |
| "A 31-year-old woman who had developed systemic lupus erythematosus at 17 years of age was admitted to the hospital for suspected cellulitis in the lower extremities." | 1.38 | Recurrent Helicobacter cinaedi cellulitis and bacteremia in a patient with systemic lupus erythematosus. ( Asahara, M; Asako, K; Kawakami, S; Kikuchi, H; Koshio, O; Ono, Y; Tansho, S; Ubagai, T; Ueda, T, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (50.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bigaré, M | 1 |
| Lesaffre, X | 1 |
| Delassus, JL | 1 |
| Bakir, R | 1 |
| Bouldouyre, MA | 1 |
| Hansen, C | 1 |
| Skov, M | 1 |
| Kikuchi, H | 1 |
| Asako, K | 1 |
| Tansho, S | 1 |
| Ueda, T | 1 |
| Koshio, O | 1 |
| Ubagai, T | 1 |
| Asahara, M | 1 |
| Kawakami, S | 1 |
| Ono, Y | 1 |
| Talbot, GH | 1 |
| Thye, D | 1 |
| Das, A | 1 |
| Ge, Y | 1 |
| Hollingsworth, JA | 1 |
| Donohoe, JF | 1 |
| Hone, R | 1 |
| Keelan, PJ | 1 |
| Bonina, L | 1 |
| Carbone, M | 1 |
| Matera, G | 1 |
| Teti, G | 1 |
| Joysey, HS | 1 |
| Hormaeche, CE | 1 |
| Mastroeni, P | 1 |
| Puppo, P | 1 |
| Germinale, F | 1 |
| De Rose, AF | 1 |
| Hoepelman, AI | 1 |
| Bakker, LJ | 1 |
| Verhoef, J | 1 |
| Pribyl, C | 1 |
| Salzer, R | 1 |
| Beskin, J | 1 |
| Haddad, RJ | 1 |
| Pollock, B | 1 |
| Beville, R | 1 |
| Holmes, B | 1 |
| Mogabgab, WJ | 1 |
| Childs, SJ | 1 |
1 review available for aztreonam and Recrudescence
| Article | Year |
|---|---|
Evidence for the efficacy of aztreonam for inhalation solution in the management of Pseudomonas aeruginosa in patients with cystic fibrosis.
Topics: Administration, Inhalation; Anti-Bacterial Agents; Aztreonam; Cystic Fibrosis; Humans; Pseudomonas a | 2015 |
6 trials available for aztreonam and Recrudescence
| Article | Year |
|---|---|
Phase 2 study of ceftaroline versus standard therapy in treatment of complicated skin and skin structure infections.
Topics: Adult; Anti-Bacterial Agents; Aztreonam; Ceftaroline; Cephalosporins; Female; Humans; Male; Methicil | 2007 |
Clinical experience with aztreonam in urinary and respiratory tract infections.
Topics: Adult; Aged; Anti-Bacterial Agents; Aztreonam; Clinical Trials as Topic; Escherichia coli Infections | 1984 |
[Aztreonam vs norfloxacin: a comparative study of the treatment of urinary tract infections in ambulatory and hospitalized patients].
Topics: Administration, Oral; Adult; Aged; Ambulatory Care; Aztreonam; Clinical Trials as Topic; Cystitis; F | 1989 |
Carumonam (Ro 17-2301; AMA-1080) compared with gentamicin for treatment of complicated urinary tract infections.
Topics: Adult; Aged; Anti-Bacterial Agents; Aztreonam; Drug Evaluation; Female; Gentamicins; Humans; Injecti | 1988 |
Aztreonam in the treatment of serious orthopedic infections.
Topics: Adult; Aged; Anti-Bacterial Agents; Arthritis, Infectious; Aztreonam; Bacterial Infections; Clinical | 1985 |
Aztreonam in the treatment of urinary tract infection.
Topics: Anti-Bacterial Agents; Aztreonam; Cefamandole; Cross Infection; Drug Resistance, Microbial; Escheric | 1985 |
3 other studies available for aztreonam and Recrudescence
| Article | Year |
|---|---|
[Relapse of Escherichia coli meningitidis due to sacral meningocele in Marfan syndrome, treated only with antibiotherapy].
Topics: Abnormalities, Multiple; Anti-Bacterial Agents; Aztreonam; Escherichia coli; Female; Humans; Magneti | 2014 |
Recurrent Helicobacter cinaedi cellulitis and bacteremia in a patient with systemic lupus erythematosus.
Topics: Adult; Anti-Bacterial Agents; Aztreonam; Bacteremia; Cellulitis; Communicable Diseases, Emerging; Fe | 2012 |
Beta-lactam antibiotics (aztreonam, ampicillin, cefazolin and ceftazidime) in the control and eradication of Salmonella typhimurium in naturally resistant and susceptible mice.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Aztreonam; Carrier State; Cefazolin; Ceftazidime; Immuni | 1990 |